NCT01160094View on ClinicalTrials.gov

Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO)

CompletedOBSERVATIONAL
Enrollment

288

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Cancer
Interventions
DRUG

Treatment

patients treated with Lapatinib-Capecitabine after Trastuzumab Progression

Trial Locations (10)

21499

Novartis Investigative Site, Jeddah

Unknown

Novartis Investigative Site, Bogotá

Novartis Investigative Site, Bucaramanga

Novartis Investigative Site, Medellín

Novartis Investigative Site, Pasto

Novartis Investigative Site, Pereira

Novartis Investigative Site, Jeddah

Novartis Investigative Site, Riyadh

Dammam 31444

Novartis Investigative Site, Dammam

jEDDAH 21423

Novartis Investigative Site, Jeddah

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY